A61K 47/6851
The antibody targeting a determinant of a tumour cell
Official title: {the antibody targeting a determinant of a tumour cell}
A61K47/6851 (The antibody targeting a determinant of a tumour cell) appears on 2,611 US grants and 5,037 published applications in this corpus.
Search patents in A61K- Granted patents
- 2,611
- Published applications
- 5,037
- Assignees
- 1,300
- Inventors
- 7,456
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 2 | 0 |
| 1988 | 0 | 0 |
| 1989 | 5 | 0 |
| 1990 | 9 | 0 |
| 1991 | 5 | 0 |
| 1992 | 6 | 0 |
| 1993 | 7 | 0 |
| 1994 | 7 | 0 |
| 1995 | 4 | 0 |
| 1996 | 8 | 0 |
| 1997 | 14 | 0 |
| 1998 | 17 | 0 |
| 1999 | 27 | 0 |
| 2000 | 18 | 0 |
| 2001 | 11 | 4 |
| 2002 | 12 | 34 |
| 2003 | 14 | 36 |
| 2004 | 16 | 50 |
| 2005 | 11 | 61 |
| 2006 | 23 | 62 |
| 2007 | 19 | 71 |
| 2008 | 32 | 79 |
| 2009 | 40 | 97 |
| 2010 | 43 | 80 |
| 2011 | 40 | 116 |
| 2012 | 57 | 101 |
| 2013 | 65 | 119 |
| 2014 | 79 | 190 |
| 2015 | 102 | 227 |
| 2016 | 159 | 331 |
| 2017 | 196 | 333 |
| 2018 | 173 | 331 |
| 2019 | 189 | 316 |
| 2020 | 204 | 286 |
| 2021 | 206 | 317 |
| 2022 | 145 | 309 |
| 2023 | 184 | 362 |
| 2024 | 176 | 402 |
| 2025 | 172 | 407 |
| 2026 | 112 | 316 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- A61K 47/6855The tumour determinant being from breast cancer cell761
- A61K 47/6869The tumour determinant being from a cell of the reproductive system: ovaria405
- A61K 47/6867The tumour determinant being from a cell of a blood cancer374
- A61K 47/6863The tumour determinant being from stomach or intestines cancer cell260
- A61K 47/6857The tumour determinant being from lung cancer cell229
- A61K 47/6859The tumour determinant being from liver or pancreas cancer cell202
- A61K 47/6865The tumour determinant being from skin, nerves or brain cancer cell192
- A61K 47/6861The tumour determinant being from kidney or bladder cancer cell149
All 9 subgroupsShow fewer
Recent patents
- Bifunctional molecules for lysosomal targeting and related compositions and methods6 Oct 2026US 12,753,239 B2The Board of Trustees of the Leland Stanford Junior University
- Monoclonal antibody used for diagnosis and early onset of prostate cancer6 Oct 2026US 12,753,244 B2Taipei Medical University
- Methods of treating residual breast cancer with trastuzumab emtansine22 Sep 2026US 12,740,962 B2Genentech, Inc.
- Antibody, antibody-drug conjugate thereof and use thereof22 Sep 2026US 12,742,009 B2Evopoint Biosciences Co., Ltd.
- Methods for treating cancer using x-ray-induced near infrared photoimmunotherapy8 Sep 2026US 12,728,164 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Delivery of dual payload of mmaf or mmae and tlr7 agonists8 Oct 2026US 2026/0306648 A1The Research Foundation for The State University of New York
- Camptothecin drug conjugate and use thereof8 Oct 2026US 2026/0306650 A1Shanghai Zaimo Biotechnology Co., Ltd.
- Anti-trop2 antibody-drug conjugates comprising pnu-159682 derivatives8 Oct 2026US 2026/0306652 A1Merck Sharp & Dohme Corp.
- Conjugates comprising cleavable linkers8 Oct 2026US 2026/0306654 A1AstraZeneca AB
- Slc4a1 (band 3) binding single domain antibodies for increased blood retention8 Oct 2026US 2026/0308272 A1
Most cited
By later US patents
- Monomethylvaline compounds capable of conjugation to ligands486US 7,498,298 B2Seattle Genetics, Inc. · 2009
- Cysteine engineered antibodies and conjugates485US 7,521,541 B2Genetech, Inc. · 2009
- Immunoconjugates and humanized antibodies specific for B-cell lymphoma and leukemia cells304US 5,789,554 AImmunomedics, Inc. · 1998
- Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease256US 7,659,241 B2Seattle Genetics, Inc. · 2010
- Compositions for targeting the vasculature of solid tumors254US 6,051,230 ABoard of Regents, The University of Texas System · 2000